Trials / Enrolling By Invitation
Enrolling By InvitationNCT06624189
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,300 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Auto-pended bot liver ultrasound order | This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis. |
Timeline
- Start date
- 2024-11-20
- Primary completion
- 2026-04-24
- Completion
- 2026-07-24
- First posted
- 2024-10-02
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06624189. Inclusion in this directory is not an endorsement.